Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 1/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/04/19

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 1B

Description: Variable importance plot (VIP) scores obtained within partial least square discriminant analysis describing the most discriminant species in Pre-CT TNM stage I (orange) compared to Pre-CT TNM stage II-III (blue)

Abundance in Group 1: decreased abundance in Pre-CT Stage II/III

NCBI	Quality Control	Links
Mitsuokella multacida
Sanguibacteroides justesenii
Clostridiales bacterium 1_7_47FAA
Victivallis vadensis
Firmicutes bacterium CAG:110
Lachnoclostridium sp. An138
Ruminococcus sp. CAG:488
Lawsonibacter asaccharolyticus
Desulfovibrionaceae bacterium
[Ruminococcus] lactaris
Butyrivibrio crossotus
Pseudoflavonifractor sp. An184
Bacteroides sp. CAG:443
Enorma massiliensis
Butyrivibrio sp. CAG:318
Ruminococcus sp. CAG:403
Pseudoflavonifractor capillosus
Barnesiella intestinihominis
Anaeromassilibacillus sp. An250
Methanobrevibacter smithii
Desulfovibrio piger

Revision editor(s): Scholastica